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Abstract
Background: Antibiotics are not only small molecules with therapeutic activity in killing or inhibiting microbial
growth, but can also act as signaling molecules affecting gene expression in bacterial communities. A few studies
have demonstrated the effect of tobramycin as a signal molecule on gene expression at the transcriptional level
and its effect on bacterial physiology and virulence. These have shown that subinhibitory concentrations (SICs) of
tobramycin induce biofilm formation and enhance the capabilities of P. aeruginosa to colonize specific
environments.
Methods: Environmental P. aeruginosa strain PUPa3 was grown in the presence of different concentrations of
tobramycin and it was determined at which highest concentration SIC, growth, total protein levels and translation
efficiency were not affected. At SIC it was then established if phenotypes related to cell-cell signaling known as
quorum sensing were altered.
Results: In this study it was determined whether tobramycin sensing/response at SICs was affecting the two
independent AHL QS systems in an environmental P. aeruginosa strain. It is reasonable to assume that
P. aeruginosa encounters tobramycin in nature since it is produced by niche mate Streptomyces tenebrarius. It was
established that SICs of tobramycin inhibited the RhlI/R system by reducing levels of C4-HSL production. This effect
was not due to a decrease of rhlI transcription and required tobramycin-ribosome interaction.
Conclusions: Tobramycin signaling in P. aeruginosa occurs and different strains can have a different response.
Understanding the tobramycin response by an environmental P. aeruginosa will highlight possible inter-species
signalling taking place in nature and can possible also have important implications in the mode of utilization for
human use of this very important antibiotic.
Background
Aminoglycoside antibiotics are clinically very important
therapeutics widely used for treatment of chronic bac-
terial infections caused by Gram-negative bacteria. They
bind to a specific domain of the prokaryotic 30 S riboso-
mal subunit and interfere with protein synthesis causing
either inhibition of cell growth or cell death [1,2]. For
example, tobramycin, an aminoglycoside produced by
Streptomyces tenebrarius is commonly used for its
effectiveness against opportunistic cystic fibrosis (CF)
infections of Pseudomonas aeruginosa [3]. Tobramycin
affects protein synthesis by binding to the A site of the
30 S ribosomal subunit [4], interacting with the A1408
residue (E. coli numbering) of the decoding site 16 S
rRNA [5].
It has recently been reported, that antibiotics are not
only small molecules with therapeutic activity in killing
or inhibiting microbial growth, but can also act as sig-
naling molecules affecting gene expression in bacterial
communities [6-9]. Bacterial signaling molecules are
defined as being able to (i) elicit a response unrelated to
the metabolism or detoxification of the signaling mole-
cule, (ii) accumulate extracellularly, (iii) generate a coor-
dinated response once a critical concentration is
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studies are beginning to lay the foundation that antibio-
tics can modulate global transcription also by affecting/
interfering with known global cascade responses [10-12].
This signaling activity occurs at much lower concentra-
tions than those required for antibiosis being as low as
1% or as high as 50% of those required for inhibition
(which is referred to as minimal inhibitory concentra-
tion or MIC) depending on the compound. The concen-
tration at which antibiotic signaling is studied are in
subinhibitory antibiotic concentrations, or SICs. SIC of
antibiotics have been shown to affect several phenotypes
in diverse bacteria through induced transcription modu-
lation including virulence functions in group A strepto-
cocci [13], virulence and motility in Salmonella
typhimurium [9] and biofilm formation in Pseudomonas
aeruginosa [14].
A few studies have demonstrated the effect of tobra-
mycin as a signal molecule on gene expression at the
transcriptional level [10,11] and its effect on bacterial
physiology and virulence [14]. These studies have shown
that low SICs of tobramycin induce biofilm formation
[14] and enhance the capabilities of P. aeruginosa to
colonize specific environments [11]. The response to
SICs has therefore, important implications on the anti-
biotic therapy of P. aeruginosa infections, but the mole-
cular mechanisms governing this response are currently
unknown.
In P. aeruginosa, the regulation of many virulence
associated factors, as well as biofilm formation, are
under regulation of two hierarchically arranged N-acyl
homoserine lactone (AHL) quorum-sensing (QS) sys-
tems, namely the LasI/R and RhlI/R systems [3]. Each
system contains one gene encoding AHL sensor/tran-
scriptional regulator, i.e. lasR and rhlR,a n dag e n e
encoding an autoinducer synthase, i.e. lasI and rhlI,
required for the synthesis of the autoinducer molecules
N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-
C12-HSL) and N-(butanoyl)-L-homoserine lactone (C4-
HSL), respectively (reviewed by [3,15,16]). At high cell
density in a situation of quorum AHL concentrations,
3-oxo-C12-HSL and C4-HSL interact directly with the
cognate LasR and RhlR sensor/regulator affecting tran-
scription of target genes.
Since QS is a global regulatory mechanism coordi-
nated by bacterial communities, scientists have begun to
investigate the possible link with antibiotic signalling.
For example the response of P. aeruginosa to the macro-
lide antibiotic azithromycin studied by microarray, pro-
teomics and phenotype analysis revealed that there is a
large common subset of genes regulated by QS and azi-
thromycin [14,17,18]. These studies demonstrated that
azithromycin has considerable QS-antagonistic effects
thus when applied it improves P. aeruginosa infections
of CF patients. In fact, SIC of azithromycin were shown
by microarray analysis to repress a large number of
genes which are QS regulated and similar observations
were made with other antibiotics [12]. In this study we
were interested to determine whether tobramycin sen-
sing/response at SICs was affecting the two AHL QS
systems in P. aeruginosa. In this study we used an envir-
onmental isolate of P. aeruginosa PUPa3 in which the
two AHL QS systems were not hierarchically organized.
The reason for performing these studies using an envir-
onmental isolate of P. aeruginosa was because the pro-
ducer of tobramycin, Streptomyces tenebrarius, lives in
similar niches of P. aeruginosa hence it was of interest
to determine if inter-species signalling could take place
between them.
Methods
Bacterial strains, plasmids and growth conditions
Strains, plasmids and primers used in this study are
listed in Table 1. P. aeruginosa PUPa3 has been pre-
viously isolated from the rice rhizosphere in India [19].
For DNA transformations E. coli DH5a was used [20]
while for triparental matings we used E. coli DH5a
(pRK2013) as helper [21]. Cultures were grown at 37°C
aerobically in Luria-Bertani (LB) broth or 1.5% agar
(Bacto-agar, BD Difco) plates containing appropriate
antibiotics. P. putida was grown at 30°C. Antibiotics
were added when required at the following final con-
centrations: ampicillin 100 μg/mL, tetracycline 15 μg/
mL (E. coli)o r1 0 0μg/mL (Pseudomonas), gentamicin
100 μg/mL (Pseudomonas); kanamycin 100 μg/mL,
chloramphenicol 25 μg/mL (E. coli)o r2 5 0μg/mL
(Pseudomonas).
DNA manipulations and plasmid constructs
Recombinant DNA techniques, including digestion with
restriction enzymes, agarose gel electrophoresis, purifi-
cation of DNA fragments, ligation with T4 ligase and
transformation of E. coli were performed as described
[22]. Plasmids pLASI and pRHLI were constructed as
follows. The lasI gene and rhlI gene promoters were
amplified using P. aeruginosa PUPa3 chromosomal
DNA as template and using primers lasI-fw/lasI-rv and
rhlI-fw/rhlI-rv respectively, listed in Table 1. PCR frag-
ments were ligated in pMOSBlue and digested with
EcoRI and XbaI or EcoRI and KpnI respectively and
then ligated in the lacZ promoterless cloning vector
pMP220, yielding pLASI and pRHLI respectively. The
rhlR gene was amplified from PUPa3 chromosomal
DNA and ligated into pGEM cloning vector, then
digested with KpnI and HindIII and ligated into the cor-
responding sites of pQE30 generating pQERHLR.
Methyltransferase genes rmtA and rmtC were kindly
provided from Dr. Jason P. Rife (University of North
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coding genes for rmtA and rmtC respectively. The
npmA gene synthesis was ordered from the Epoch Bio-
labs, INC. following the sequence published in [23]. The
gene was subsequently cloned in pBBRmcs3 with
restriction sites XbaI and SacI generating pNPMA. rmtA
and rmtC were cloned in pET-25b(+) vectors with
restriction sites NdeI and XhoI after PCR amplification
using primers RmtA-fw/RmtA-rv and RmtC-fw/RmtC-
rv respectively. PCR fragments were then ligated in
pMOSBlue, digested with KpnI and XhoI or PstI and
SpeI respectively and ligated in pBBRmcs3 generating
pRMTA and pRMTC. All plasmid constructs were veri-
fied by DNA sequencing (Macrogen, Korea).
Table 1 Strains, plasmids and primers used
Strains, Plasmids
and Primers
Characteristics Reference or
source
Strains
Pseudomonas
aeruginosa
PUPa3 Wild type, rice rhizosphere isolate [42]
LASI lasI::Km of P. aeruginosa PUPa3; Km
r [43]
RHLI rhlI::Gm of P. aeruginosa PUPa3; Gm
r [43]
DMI lasI::Km rhlI::Gm of P. aeruginosa PUPa3; Km
r Gm
r [43]
Pseudomonas putida
SM17 rsaL::Tc of P. aeruginosa PUPa3; Tc
r [43]
E. coli
M15(pRep4) Derivative of E. coli K-12, containing pREP4 plasmid ensuring the production of high levels of lac
repressor protein; Km
r
Qiagen
DH5a F’/endA1 hsdR17 supE44 thi-1 recA1 gyrA relA1 (lacZYA-argF)U169 deoR [80dlac(lacZ)M15recA1] [44]
Plasmids
pMP220 Promoter probe vector, IncP1; Tc
r [45]
pMOSBlue Cloning vector; Amp
r Amersham-
Pharmacia
pGEM-T Easy Cloning vector; Amp
r Promega
pBBRmcs3 Broad-host-range vector; Tc
r [46]
pQE30 Expression vector, Amp
r Qiagen
pRTLF-1 rpoS-lacZ translational fusion in pMP77; Cm
r [47]
pSB406 contains a fusion of rhlRI’::luxCDABE in pUC18; Amp
r [48]
pSB536 ahyR
+ ahyI::luxCDABE; ColE1 origin; Amp
r [49]
pRK2013 Tra
+ Mob
+ ColE1 replicon; Km
r [50]
pRPO220 pMP220 containing promoter rpoS;T c
r [51]
pRSAL220 pMP220 containing promoter rsaL;T c
r [47]
pRHLI pMP220 containing promoter rhlI;T c
r This study
pLASI pMP220 containing promoter lasI;T c
r This study
pQERHLR pQE30 containing rhlR; Amp
r This study
pRMTA pBBR3 containing rmtA;T c
r This study
pRMTC pBBR3 containing rmtC;T c
r This study
Primers
RhlR-fw GGGGTACCAGGAATGACGGAGGCTTTTTG This study
RhlR-rv GAAGCTTGATGAGGCCCAGCGCCGCGG This study
rhlI-fw CCGAATTCCACCACAAGAACATCC This study
rhlI-rv ATGGTACCAGCGATTCAGAGAGCAA This study
lasI-fw GGAATTCGGGCTGTGTTCTCTCGTGTG This study
las-rv CTCTAGAGAACTCTTCGCGCCGACCAA This study
RmtA-fw GGGTACCAATAATTTTGTTTAACTTTA [52]
RmtA-rv CCCTCGAGTCACTTATTCC This study
RmtC-fw ATCTGCAGAATAATTTTGTTTAACTTTA This study
RmtC-rv ATACTAGTTTACAATCTCGATACGAT This study
Ap
r,K m
r,T c
r,G m
r, and Cm
r, resistant to ampicillin, kanamycin, tetracycline, gentamicin, and chloramphenicol, respectively
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The minimal inhibitory concentration (MIC) of tobra-
mycin (Sigma-Aldrich) for P. aeruginosa PUPa3 was
determined in LB broth after 24 hours incubation at
37°C using the MIC dilution method as previously
described [24]. Briefly, overnight cultures of PUPa3 were
diluted 100 fold in fresh LB medium and grown until
the OD600 of 1. LB medium containing various concen-
trations of tobramycin (0.05 - 320 μg/mL) was inocu-
lated with 10
6 cells and grown in microtiter plates. MIC
was determined as a minimal concentration of tobra-
mycin that prevents the visible growth of bacteria.
Determination of growth rate and of total cell protein
and b-galactosidase assay
Growth curves were performed in duplicates in LB or LB
medium supplemented with various concentrations of
tobramycin (1/16, 1/8, 1/4, 1/2 of MIC). Overnight cul-
ture of P. aeruginosa PUPa3 was diluted 100 fold in fresh
LB medium and cultures were grown at 37°C measured
the OD600 every 20 minutes. b-galactosidase activities
were determined by the Miller method [22] and levels of
proteins were determined by the Bradford assay [25].
Determination of swarming ability, proteolytic activity
and biofilm formation
Swarming assay was performed on 0.5% LB agar plates
as previously described [26] supplemented with SIC of
tobramycin (25% of MIC). 1.5 μl of overnight culture of
PUPa3 was inoculated on swarming plates and incu-
bated at 37°C for 24 hours. Synthetic C4-HSL (pur-
chased from Fluka-Sigma-Aldrich) was added in agar
plates in final concentration of 2 μM. Proteolytic activity
was determined in the appropriate indicator plates as
previously reported [27] in presence or absence of 25%
of MIC of tobramycin and grown at 37°C after 24 hours.
Biofilm formation was quantified by measuring A570 of
crystal-violet staining of adherent cells. 2 ml of over-
night culture from P. aeruginosa PUPa3 grown in AB
minimal medium was centrifuged and pellet was washed
in fresh media. New inoculum of OD600 of 0,01 was
grown at 37°C for 24 hours in wells of 96-well poly-
styrene microtiter plates (Nunc) using 100 μlo fc u l t u r e
per well (16 duplicates per condition per experiment).
Planktonic cells were removed and the wells with adher-
ent biofilms were stained using 0,1% crystal-violet for
30 min at room temperature, washed three times with
water and dried. To solubilize adsorbed crystal violet,
150 μl of DMSO was added in each well and incubated
for 20 minutes. The absorbance was read at 570 nm.
Unpaired t-test and ANOVA test (Prisma 5.5 software,
GraphPad Software, San Diego, California) was used
to establish significance of differences between means
(P value of < 0,005). MIC was determined for the
planktonic cells in the culture used as the inoculum.
MIC of tobramycin was 8 μg/ml and 25% of MIC was
used as subinhibitory concentration.
Extraction of AHL signal molecules
For the extraction of the AHL molecules, P. aeruginosa
PUPa3 was grown until OD600 reached 2 in 50 ml of LB
medium or LB medium supplemented with SIC of
tobramycin, and supernatant of the culture was
extracted with an equal volume of ethyl acetate acidified
with 0.1% acetic acid. The extract was then dried and
resuspended in a small volume of ethyl acetate as
previously described [26].
Determination of C4-HSL, of 3-oxo-C12-HSL and of
pyocyanin levels
C4-HSL levels were determined as follows. Biolumines-
cence assay was performed using biosensors specific for
C4-HSL, i.e. E. coli pSB406 [28] and E. coli pSB536 [29].
Overnight liquid cultures of the two reporter strains
were diluted 1:100 in LB and grown till OD600 of 1 then
added to the wells of black clear-bottom 96-well plates
(OptiPlate microtiter trays, Perkin-Elmer, USA) and sup-
plemented with various concentrations of synthetic
C4-HSL to generate standard curve or with various
amounts of P. aeruginosa AHL extracts. Cultures were
then grown at 37°C and OD600 and luminescence from
each well were recorded in a Wallac EnVision 2104
multilabel reader (Perkin-Elmer). Relative light intensity
of extracts of P. aeruginosa grown in the presence of
tobramycin was defined as the percentage of emitted
light (British light units) under these conditions com-
pared with the mean value of P. aeruginosa extracts
grown without antibiotic.
3-oxo-C12-HSL was determined as previously
described [30]. Briefly, b-galacotsidase activities were
measured using P. putida SM17 (pRSAL220) lacZ based
reporter strain upon addition of PUPa3 AHL extracts.
Overnight cultures of P. putida were diluted up in 5 ml
volume to an OD600 of 0.3 and P. aeruginosa AHL
extracts were added. b-galactosidase activity was mea-
sured during various stages of growth. All assays were
performed in triplicate.
Pyocyanin levels were determined as previously
described [31]. Briefly, P. aeruginosa PUPa3 was grown
with aeration at 37°C in LB broth. Each culture was
inoculated from a fresh overnight culture adjusted an
optical density at 600 nm of 0.02 before incubation.
Quantification of pyocyanin production was done by
extracting a 5 ml of culture with 3 ml of chloroform fol-
lowed by mixing with 1 ml of 0.2 M HCl. The absor-
bance of upper red phase was measured at 520 nm and
amount of pyocyanin was determined as previously
described [31].
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MIC and SIC of tobramycin for P. aeruginosa PUPa3
The MIC of tobramycin for strain PUPa3 was deter-
mined to be 0.2 μg/mL in LB broth and 2 μg/mL on LB
agar plates. We then established that 25% of the MIC of
tobramycin (i.e. 0.05 μg/mL) was subinhibitory (SIC),
since (i) it did not affect the growth rate of P. aerugi-
nosa PUPa3 in LB media (data not shown), (ii) did not
alter the protein synthesis as determined by measure-
ment of total cellular protein (data not shown) and (iii)
it did not affect translation efficiency because did not
alter b-galactosidase activity of PUPa3 harboring the
rpoS-lacZ translational fusion at various growth stages
(data not shown).
SIC of tobramycin affects swarming motility, biofilm
formation and pyocyanin production in P. aeruginosa
PUPa3
It was of interest to determine the impact of SIC of
tobramycin on the AHL QS response in P. aeruginosa
PUPa3 using swarming assays. It was previously estab-
lished that in P. aeruginosa PUPa3 swarming is regu-
l a t e db yt h eR h l I / RA H LQ Ss y s t e m[ 2 6 ] .W eo b s e r v e d
as expected that the rhlI and double mutant (lasI/rhlI)
were impaired in swarming whereas strain PUPa3
swarmed well. We then tested swarming abilities at
SIC and established that strain PUPa3 did not swarm
under these conditions indicating that 0.05 μg/mL of
tobramycin impaired swarming (Figure 1a). Impor-
tantly, swarming can then be rescued by adding exo-
genous synthetic C4-HSL, indicating that possibly the
presence of SIC of tobramycin affected the production
levels C4-HSL (Figure 1b). Biofilm formation was also
reduced when P. aeruginosa strain PUPa3 grows under
SIC of tobramycin; this reduction could then be res-
cued by the exogenous addition of C4-HSL (Figure 2).
Another phenotype previously reported to be regulated
by the RhlI/R system is the production of the toxic
pyocyanin pigment [32]. We also assayed for pyocyanin
production (Figure 3) and determined that (i) the rhlI
mutant of P. aeruginosa PUPa3 no longer produced
pyocyanin and (ii) SIC concentrations of tobramycin
reduced pyocyanin production which could be also res-
cued by addition of exogenous C4-HSL (Figure 3). It
was therefore concluded that pyocyanin in strain
PUPa3 is regulated by the RhlI/R system and that
tobramycin affected the production levels.
In order to establish whether SIC of tobramycin affected
the LasI/R AHL QS system of strain PUPa3, we assayed
for protease production since as previously determined,
protease activity is regulated by LasI/R [26]. It was estab-
lished that when P. aeruginosa was grown in the presence
of SIC of tobramycin proteolytic activity was unaltered
when compared to P. aeruginosa grown in the absence of
the antibiotic (Figure 4). It was therefore concluded that
the LasI/R system was not affected by SIC of tobramycin.
P. aeruginosa PUPa3 grown in SIC of tobramycin lowers
C4-HSL levels
In order to establish whether SIC of tobramycin affected
AHL levels we first assayed rhlI and lasI transcription
via a rhlI-lacZ and lasI-lacZ transcriptional gene promo-
ter fusions. b-galactosidase activity in strain PUPa3 har-
boring either the plasmid pRHLI or pLASI showed no
significant differences at various stages of growth in pre-
sence of SIC of tobramycin when compared to PUPa3
grown without tobramycin (Figure 5). It was therefore
concluded that SIC of tobramycin did not affect the
transcription rates of the rhlI and lasI AHLs synthases.
Levels of 3-oxo-C12-HSL from PUPa3 extracts were
then measured using the P. putida SM17 (pRSAL220)
specific 3-oxo-C12-HSL sensor and no significant differ-
ence has been detected between cultures of PUPa3 of
different growth stages grown in presence or absence of
SIC of tobramycin (Figure 6b). Two E. coli luxCDABE
based biosensors specific to C4-HSL were used in order
to establish C4-HSL levels. Bioluminescence assays
demonstrated that a significant reduction (20 - 25%) of
C4-HSL was observed when P. aeruginosa PUPa3 grown
in presence of SIC of tobramycin (Figure 6a). It was
concluded that SIC of tobramycin did not affect 3-oxo-
C12-HSL levels but did lower C4-HSL levels.
SIC of tobramycin response requires interaction with
ribosome
In order to determine the importance of tobramycin-
ribosome interaction in the signaling role in lowering
C4-HSL levels, the npmA, rmtA and rmtC methyltrans-
ferase genes were cloned and expressed in P. aeruginosa
PUPa3. These methyltransferases are known to specifi-
cally methylate nucleotides A1408 [23] and G1405
[33,34] respectively, within the decoding A site in small
ribosomal subunit which then block tobramycin-ribo-
some interaction rendering the bacterium resistant to
tobramycin. As observed above, P. aeruginosa PUPa3
could not swarm in the presence of SIC of tobramycin
but when either the npmA or rmtA or rmtC genes were
expressed using plasmids pNPMA, pRMTA and
pRMTC respectively, swarming was restored (Figure 7).
It was concluded that the observed effect of SIC of
tobramycin in affecting C4-HSL dependent swarming
involves tobramycin-ribosome interaction.
Discussion
It is important for us bacteriologists to remember that
most bacterial species in any given environment
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Page 5 of 12Figure 1 Effect of subinhibitory concentration of tobramycin on swarming motility in P. aeruginosa PUPa3. a) Swarming of P. aeruginosa
PUPa3 on 0.5% LB agar plates at 37°C after 24 hrs. WT swarms (A), but in presence of SIC of tobramycin (0.05 μg/mL) cannot swarm (B).
Swarming was not present in the rhlI mutant (C) nor in double mutant lasI/rhlI (D). b) Swarming of P. aeruginosa PUPa3 on 0.5% LB agar plates
at 37°C after 40 hrs. Normal swarming occurs in WT (A), no swarming is present in WT on plate supplemented with SIC of tobramycin (B) and
swarming was restored upon the addition of 2 μM exogenous synthetic C4-HSL (C). Swarming in the rhlI mutant was also restored upon the
addition of 2 μM exogenous synthetic C4-HSL (D), but not upon the addition of 2 μM exogenous synthetic 3-oxo-C12-HSL (E).
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meaning that bacteria do not live in isolation or in
monoculture but in mixed communities. It is also most
probable that in these mixed and diverse consortia there
is considerable competition as well as constant commu-
nication. It is assumed that antibiotics with inhibitory
activity are important as weapons in inter-microbial
competition. In recent years however scientists are
beginning to investigate that antibiotics have functional
interactions with cellular processes which are different
from the primary antibiotic inhibitory effect (reviewed
by [7,9]). Several studies have now shown that subinhi-
bitory concentrations (SICs; these do not affect growth
and protein synthesis) of several antibiotics can tran-
scriptionally modulate a large number of genes [10-12].
Here we began to study the effect of SICs of tobra-
mycin on an environmental isolate of P. aeruginosa.
Tobramycin is produced by Streptomyces tenebrarius
which is a soil organism and therefore probably shares
similar niches to P. aeruginosa since it is also found in
the soil. P. aeruginosa in nature therefore encounters
tobramycin and could have evolved the ability to
respond to this molecule possibly allowing adaptation to
co-exist or compete with S. tenebrarius. Importantly, P.
aeruginosa possesses an inducible resistance to tobramy-
cin [35] thus suggestive of a response and adaptive
behavior towards the compound. Since P. aeruginosa
possesses a major transcription response to AHL signals
influencing the transcription of over 6% of the genome
[16], it was of interest to determine if AHL QS was
affected by SICs of tobramycin. The P. aeruginosa
PUPa3 environmental isolate possesses the two AHL QS
systems which act independently and are not hierarchi-
cally organized [26]. To our knowledge all other studies
in P. aeruginosa involving antibiotics as signal molecules
were performed using the clinical isolates. In fact it was
previously reported that SIC of tobramycin in strain P.
aeruginosa PAO1 (clinical isolate of 1950) also induces
a reduction in C12-3-oxo-HSL and C4-HSL production
[36]. It must be noted however that the two AHL sys-
tems in strain PAO1 are organized in a hierarchy; the
Las system regulating in a cascade the rhl system [37].
SICs of tobramycin in strain PUPa3 reported here was
found to lower only the C4-HSL levels by over 20%
which was shown to be enough to inhibit swarming and
lower pyocyanin levels which are both regulated by the
Figure 2 Effect of subinhibitory concentration of tobramycin
on biofilm growth. Biofilm formation was reduced when PUPa3
was grown under subinhibitory concentration of tobramycin (Tob).
Biofilm formation was rescued by adding 2 μM exogenous C4-HSL
(Tob + C4HSL).
Figure 3 Pyocyanin production in PUPa3 in early stationary
growth phase. All strains were grown in LB media. Presence of SIC
of tobramycin in wild type significantly decreases levels of
pyocyanin production (P < 0.05). Values shown in graph are means
from three independent biological experiments, normalized to
culture density (OD600). WT, is strain PUPa3; Tob, is strain PUPa3
grown in the presence of SIC of tobramycin (0.05 μg/mL); Tob
C4HSL, is strain PUPa3 grown in the presence of SIC of tobramycin
(0.05 μg/mL) and 2 μM of C4-HSL; rhlI, is the rhlI knock-out mutant
of strain PUPa3; rhlI C4HSL, is the rhlI knock-out mutant of strain
PUPa3 grown in the presence of exogenously added 2 μMo f
C4-HSL.
Figure 4 Proteolytic activities determined in the appropriate
indicator LB plates. The P. aeruginosa lasI mutant (A) showed four-
fold reduced proteolytic activity compared to WT (B). WT shows no
difference in proteolytic activity in the presence of 0.05 μg/mL SIC
of tobramycin (C).
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Page 7 of 12Figure 5 lasI and rhlI gene promoter activities and quantitative
determination of 3-oxo-C12-HSL. a)lasI gene promoter activities
measured via b-galactosidase assay in PUPa3 in different stages of
growth. The white colorless bars represents the control culture
P. aeruginosa PUPa3 with the vector pMP220; light grey represents
P. aeruginosa PUPa3 harboring pLASI; dark grey, represents P.
aeruginosa PUPa3 harboring pLASI with addition of SIC of
tobramycin (0.05 μg/mL). b) rhlI gene promoter activities measured
via b-galactosidase assay in PUPa3 in different stages of growth. The
white colorless bars represents the control culture P. aeruginosa
PUPa3 with the vector pMP220; light grey represents P. aeruginosa
PUPa3 harboring pRHLI; dark grey, represents P. aeruginosa PUPa3
harboring pRHLI with addition of SIC of tobramycin (0.05 μg/mL).
The b-galactosidase activities were performed at different stages of
growth: assay 1 was performed during log phase, assay 2 during
early stationary phase, assay 3 and assay 4 during stationary phase.
Each assay was performed in biological triplicates. Error bars
represent the standard deviations calculated from at least three
separate experiments.
Figure 6 C4-HSL and 3-oxo-C12-HSL quantification. a) C4-HSL
quantification using two E. coli luxCDABE specific C4-HSL biosensors
harbored in pSB406 and pSB536. Bioluminescence induced by AHL
extracts of PUPa3 corresponding to 7 × 10
9 cells grown in presence
of SIC of tobramycin (0.05 μg/mL) at 37°C was defined as the
percentage relative to the same strain without antibiotic (white bar).
Each assay was an independent experiment measured in triplicates.
+/- represents extract from PUPa3 grown in presence or absence of
SIC of tobramycin added to biosensor culture. b) 3-oxo-C12-HSL
quantification: the columns represent the 3-oxo-C12-HSL
quantification determined by using the biosensor P. putida SM17
(pRSAL220). E represents 5 ml of biosensor culture supplemented
with 5 μl ethyl-acetate, +/- addition of 5 μl of AHL extract of PUPa3
(equivalent to 9.2 × 10
9 cells) grown in presence or absence of SIC
of tobramycin (0.05 μg/mL).
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Page 8 of 12RhlI/R system. Importantly both of these effects were
recovered upon addition of exogenous C4-HSL indicat-
ing that they were entirely due to interference with the
RhlI/R system. Importantly in strain PUPa3 the levels of
C12-3-oxo-HSL were not affected by SICs of tobramycin
possibly indicating that the independent organization of
the two systems allows them to respond differently to
environmental conditions. Another study involving P.
aeruginosa PAO1, has also reported effects by tobramy-
cin signaling. Linares et al. [11], have reported that SIC
of tobramycin induces swarming as well as biofilm for-
mation in P. aeruginosa P A O 1 .T h i si sc o n t r a s to fw h a t
we report here and what was reported by Luke et al.
[36] since we observed a decrease in swarming and bio-
film formation when P. aeruginosa PUPa3 is exposed to
S I C so ft o b r a m y c i n .I ti sm o s tl i k e l yt h a tt o b r a m y c i n
signaling can have different effects in different strains
when grown in different growth conditions. In fact
another recent study reported that SICs of tobramycin
in P. aeruginosa PAO1 did not inhibit AHL QS [12] as
we observe for strain PUPa3. Three antibiotics however
were reported to inhibit AHL QS at SIC in P. aerugi-
nosa PAO1 [12]; interestingly these antibiotics, namely
floroquinolone, cephalosporin and azithromycin, belong
to different classes. The inhibition of the RhlI/R system
in strain PUPa3 by SIC of tobramycin observed here is
similar to what was reported for azithromycin signaling
in strain PAO1, however in PAO1 both Las and Rhl sys-
tems are inhibited [18,38,39]. Interestingly this inhibition
is also not due to a decrease in the transcription of the
AHL QS systems but apparently to an effect on loci
upstream the lasI/R and rhlI/R systems [38]. It therefore
appears that there are some common features between
the signaling response of strain PAO1 to azithromycin
and tobramycin signaling in strain PUPa3.
How does SIC of tobramycin affect the RhlI/R system?
The fact that the LasI/R system was not affected showed
that the SIC of tobramycin effect is specific for the RhlI/
R system. Since a few studies have reported that SIC of
several antibiotics affected gene transcription, we
Figure 7 Swarming of P. aeruginosa PUPa3 on 0.5% LB agar plates at 37°C after 24 hrs. In the presence of SIC tobramycin (0.05 μg/mL)
no swarming is present in WT (B), but the swarming was restored with the expression of RmtA (C), RmtC (D) or NpmA (E) methyltransferases as
in LB plates inoculated with WT (A).
Babić et al. BMC Infectious Diseases 2010, 10:148
http://www.biomedcentral.com/1471-2334/10/148
Page 9 of 12analyzed whether rhlI transcription levels changed at
SICs of tobramycin. The rhlI transcription levels did not
change upon exposure to SIC of tobramycin at various
growth stages indicating that the lower C4-HSL levels
were not due to a decrease of rhlI transcription. It can-
n o tb ee x c l u d e dt h a tt h i sc o u l db ed u et oa ne f f e c to n
rhlI translation; recently it has been reported that a
novel protein designated GidA, post-transcriptionally
controls RhlI/R levels [40]. In addition, tobramycin at
subinhibitory concentrations could result in lower pools
of the precursors necessary for C4-HSL biosynthesis or
possibly the transport of the AHL could also be affected.
The C4-HSL however has been shown that when added
to cell suspensions of P. aeruginosa, the cellular concen-
tration reached a steady state in less than 30 seconds
being equal to the external concentration, hence it can
be regarded as a freely diffusible compound [41]. Future
studies need to determine the cellular targets which are
affected by subinhibitory concentrations of tobramycin
which result in lower C4-HSL levels in P. aeruginosa
PUPa3. Previous studies in P. aeruginosa PAO1 have
identified a gene called arr which is involved in tobra-
m y c i ns i g n a l i n ga tS I C[ 1 4 ]w h i c hr e s u l t si na ni n d u c -
tion of biofilm formation. This gene encodes for an
inner membrane protein and it was postulated to
respond to tobramycin and affect surface appendages
which are important for biofilm formation. The mode of
action of Arr is currently unknown but it is believed to
occur via the second messenger c-di-GMP since arr
mutants are less active in degrading c-di-GMP [14]. It is
currently unknown whether reduction of AHL levels by
tobramycin signaling occurs via arr.
The tobramycin signaling reported here requires the
interaction of tobramycin with the ribosome since ribo-
somal protection by methylation using the NpmA, RmtA
and RmtC methyltransferases relieves signaling since
SICs of tobramycin no longer affect the RhlI/R system.
Tobramycin blocks the peptide exit channel by binding
to the A1408 residue of 16 S rRNA and the three methyl-
transferases specifically methylate nucleotides A1408 [23]
and G1405 [33,34] respectively, within the decoding A
site in 16 S rRNA, no longer allowing tobramycin bind-
ing. Interestingly azithromycin signaling at SIC in strain
PAO1 also requires interaction with the ribosome since
similar experiments demonstrated that the ErmAB
methyltranserase which blocks azithromycin interaction
with the 23 S rRNA stops signalling at SICs [39]. These
observations indicate that antibiotic signaling requires
interaction with the ribosome possibly meaning the regu-
latory cascade is initiated at the ribosome.
Conclusions
In summary this study has further highlighted the pre-
sence of antibiotic signaling in P. aeruginosa and that
different strains can have a different response. The role
of antibiotics as signaling molecules now needs to be
further evidenced by unraveling the molecular mechan-
isms of the cascade identifying primary response compo-
nents which trigger the regulatory cascade.
Understanding the tobramycin response by P. aerugi-
nosa will have important implications in the mode of
utilization for human use of this very important
antibiotic.
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